Vitality Watch

Dossier pubmed observational 21-sep-2026
Human cohort, case-control, or epidemiological association

Gait Speed and Survival in Those With Exceptional Longevity: The LifeAfter90 Study.

Key claim: In an ethnoracially diverse LifeAfter90 cohort of adults aged 90+, each SD faster gait speed was associated with ~20% lower all-cause mortality after demographic adjustment, with the association clear at ages 90–94 and attenuated at 95+.

Abstract

BACKGROUND: Although gait speed is a well-established predictor of mortality, it is understudied among ethnoracially diverse oldest-old cohorts. We examined the association between gait speed and all-cause mortality in an ethnoracially diverse 90+ population. METHODS: We examined the association between gait speed and survival over an average follow up of 3.6 ± 2.0 years. Follow-up time was defined as years from baseline to death, loss to follow-up, refusal, or study end, June 19, 2025, whichever occurred first. Baseline gait speed (m/s) was measured using the 4-meter walk test. Cox proportional hazards model evaluated associations between gait speed and mortality, adjusting for age, sex/gender, race/ethnicity, and education. Interactions by sex/gender, age, race/ethnicity, and device were tested. RESULTS: Among 502 participants (M92.9 ± 2.4 years; 62.6% women; 20.9% Asian, 22.3% Black, 12.4% Latinx, 8.6% Multiracial/Other, 35.9% White), mean gait speed was 0.55 ± 0.21 m/s and 259 deaths occurred. Each 1 SD (0.21 m/s) increase in gait speed was associated with a 20% lower risk of mortality (HR = 0.80; 95% CI = 0.69-0.91) after adjustments for demographics. In this cohort, this increase corresponds to completing the 4-meter walk test about 2 s faster. The association was modified by age (p-interaction = 0.01). There were no significant differences by sex/gender, race/ethnicity or device (p-interaction > 0.1). In age-stratified analyses, faster gait speed predicted lower risk of mortality among participants aged 90-94 years (HR = 0.70; 95% CI = 0.60-0.82), whereas the results were attenuated for the 95+ group (HR = 1.02; 95% CI = 0.77-1.30). CONCLUSION: Faster gait speed was associated with a lower risk of mortality in adults aged 90 and older. These results were consistent across gender, race/ethnicity, and assistive device use, but differed by age group. Routine gait speed assessment may serve as a simple clinical tool to identify oldest-old adults at higher risk of mortality.

Why this matters

Gait speed is one of the most portable and cheap physical-function biomarkers in the aging measurement stack, and its mortality-prediction validity has largely been established in younger-old cohorts of predominantly white populations. LifeAfter90 extends that validity into an ethnoracially diverse 90+ sample while surfacing a boundary condition — the signal attenuates past 95 — which matters for anyone using gait speed as a stratification tool in the oldest-old, where most competing biomarkers also lose discrimination.

Source

Link

Briefing card

Gait Speed and Survival in Those With Exceptional Longevity: The LifeAfter90 Study.
Stage: observational · pubmed · 21-sep-2026

If you're using gait speed to gauge mortality risk in adults over 95, this cohort found the association weakens sharply compared with the 90–94 band.

In an ethnoracially diverse LifeAfter90 cohort of adults aged 90+, each SD faster gait speed was associated with ~20% lower all-cause mortality after demographic adjustment, with the association clear at ages 90–94 and attenuated at 95+.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/jgs.70716

build build 880 · 2bcef25 · 2026-11-18